"Tailor made children's medicine" dyne pharmaceutical won the science and Technology Award

[China Pharmaceutical network enterprise news] at present, there are many problems in the field of children's medicine in China, including the lack of professional children's medicine enterprises, the shortage of children's medicine, the lack of special dosage forms and other outstanding problems, which also increasingly highlights the urgency of innovation and research in children's medicine enterprises With the opening of the two child policy, the pressure of medical institutions is increasing, and the responsibility of children's pharmaceutical enterprises is more and more heavy Since its establishment in 1994, dyne pharmaceutical has been committed to promoting the orderly development of children's health cause with the mission of "making millions of Chinese children healthy and strong", and has been carrying out continuous technological innovation and research in the field of children's medicine The recent three industry science and technology awards are a strong affirmation of the company's unremitting efforts and scientific research achievements According to relevant data, there are more than 6000 pharmaceutical enterprises in China, but only about 10 professional pharmaceutical enterprises for children The prescription and technology of children's medicine are relatively complex, and the requirements for taste, safety, raw and auxiliary materials and quality control are relatively strict Facing the factors of high difficulty, small profit and high risk, many pharmaceutical enterprises lack enthusiasm for the research and development of children's medicine, which will greatly increase the difficulty for the country to carry out the work of children's health promotion Children are not the miniaturized version of adults As a special drug group, they have different physiological characteristics and drug metabolism characteristics from adults In different periods, children have different abilities of drug absorption, distribution, metabolism and excretion, and the incidence of adverse reactions is higher than that of adults In addition, because of the bad taste, the inconvenience of taking medicine and the poor compliance of taking medicine, it will also bring more difficulties for clinical treatment In our conventional cognition, many people think that only oral liquid and granules are for children In fact, there are many, such as solutions / drops, emulsions / suspensions, effervescent agents and suppositories, which are ideal dosage forms for children, especially for infants and young children In addition, transdermal drug delivery system appeared in 1980s Delivery system TDDS) has been favored by many international famous pharmaceutical companies since its appearance It is also a very suitable dosage form for infants and children Its main advantage is to remove the first pass clearance effect of the liver, avoid the stimulation of chemical and biological effects on the intestinal tract, reduce or avoid the occurrence of side effects Moreover, due to the good targeting of the drug, the dosage of the drug is greatly reduced, and the use of the patient is more convenient Especially for children, compared with the traditional way of administration, it is not only easy to operate, but also has significantly higher safety and effectiveness Adhering to "tailor-made children's medicine", dyne pharmaceutical has won the award of pharmaceutical science and technology For many years, dyne pharmaceutical has been taking "tailor-made" as the concept, finding, analyzing and solving problems from the perspective of children, and protecting the safety of children's medicine with professional R & D design and production supervision Research on improving taste, enriching dosage forms and improving children's specifications of drugs suitable for children on the market, and gradually carry out localization and R & D innovation of foreign drugs, and carry out research and development of children's drugs with independent intellectual property rights In 2011, a research and Development Center for children's specific drugs was established, and a professional degree graduate workstation was established in cooperation with the school of pharmacy of Shandong University; since 2013, it was identified as the "children's drug research base" by the Xinhua news agency economic reference; in 2014, it was approved as the enterprise technology center of Shandong Province; in 2016, it was approved to establish the children's drug engineering technology research center of Shandong Province, and in the same year, Beijing dyne was established High tech children's Drug Research Institute Co., Ltd is committed to the research and development of children's specific drugs In the face of various problems in the field of children's medicine in China, as a leading enterprise in the field of children's medicine, the first task of dyne pharmaceutical industry is to understand the varieties of children's medicine in short supply For children of different ages, the same ingredient needs to carry out pharmaceutical research of different dosage forms, specifications and tastes, and improve children's clinical data Only by "tailor-made", the safety, effectiveness and compliance of children's medication can be truly guaranteed After continuous innovation and research, dyne pharmaceutical industry has achieved fruitful results in the near future, including the taste technology research of children's oral preparations, transdermal drug release technology research and oral liquid preparations research The awards include the "2017 second prize of science and technology of Shandong Pharmaceutical Association", "the 13th third prize of Weihai Natural Science Academic Achievement Award" and "the 10th prize" The second prize of the third Weihai Natural Science Academic Achievement Award " In a short period of time, it is not only the recognition of the scientific research achievements of the enterprise, but also the full impetus for the further development of dyne pharmaceutical industry and the research and development of children's drugs In the future, dyne pharmaceutical will provide a strong guarantee and platform for the research and development innovation of children's special drugs, constantly improve the level of technological innovation, adhere to the concept of "tailor-made", safeguard the safety of children's drug use, and constantly strive for the health cause of Chinese children! Original title: adhere to "customized children's medicine"! Dyne pharmaceutical industry has won the industry science and Technology Award and seized the opportunity of pharmaceutical machinery and equipment industry Please download app (Pharma, Android version)!